Feature
Podcast
Author(s):
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
In this episode of Speaking of Urology®, Robert E. Brannigan, MD, speaks with Juan J. Andino, MD, MBA, on the recent amendment to the American Urological Association (AUA)/American Society for Reproductive Medicine (ASRM) guideline on male infertility.1 Brannigan is the vice chair of clinical urology and the chief of male reproductive medicine and men’s health at Northwestern University in Chicago, Illinois, as well as one of the Guideline Amendment Chairs for the AUA male infertility guideline. Andino is an assistant professor of urology at the University of California, Los Angeles (UCLA) Health.
This discussion originally took place during a live X (formerly Twitter) Spaces event held by Urology Times®.
During the discussion, Brannigan and Andino highlight 3 key changes to the male infertility guideline, which include:
Other key changes addressed throughout the discussion include the additional situations in which a male should be evaluated even if the semen analysis is normal; the avoidance of exogenous therapy if a patient is interested in current or near future fertility; and the situations where a scrotal ultrasound may be useful, give that is not needed as a routine test. Brannigan and Andino also touch on the potential role for seminal vesiculoscopy, which is not included in the guidelines, and the ASRM’s broadened definition of infertility.
You can subscribe to Speaking of Urology on Spotify, Apple Podcasts, or anywhere that podcasts are available.
Reference
1. Brannigan RE, Hermanson L, Kaczmarek J, Kim SK, Kirkby E, Tanrikut C. Updates to male infertility: AUA/ASRM guideline (2024). J Urol. August 15, 2024. Accessed September 23, 2024. doi:10.1097/JU.0000000000004180